C-Reactive Protein (Crp) As A Predictive Marker For Survival In Patients With Advanced Non-Small Cell Lung Cancer (Nsclc) Treated With First Line Pembrolizumab Monotherapy.
JOURNAL OF CLINICAL ONCOLOGY(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要